Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China

OBJECTIVE: To examine the clinical outcomes and associated prognostic factors among patients with multidrug-resistant tuberculosis (MDR-TB) in China.METHODS: This retrospective study involved 243 patients with MDR-TB. All patients received standard regimens containing para-amino salicylic acid (PAS)...

Full description

Saved in:
Bibliographic Details
Published inThe international journal of tuberculosis and lung disease Vol. 22; no. 3; pp. 300 - 305
Main Authors Fan, Y-M., Ding, S-P., Bao, Z-J., Wu, L-M., Zhen, L-B., Xia, Q., Zhu, M.
Format Journal Article
LanguageEnglish
Published France International Union Against Tuberculosis and Lung Disease 01.03.2018
International Union against Tuberculosis and Lung Disease (IUATLD)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:OBJECTIVE: To examine the clinical outcomes and associated prognostic factors among patients with multidrug-resistant tuberculosis (MDR-TB) in China.METHODS: This retrospective study involved 243 patients with MDR-TB. All patients received standard regimens containing para-amino salicylic acid (PAS) and/or cycloserine (CS). The demographic, social and clinical characteristics of patients were recorded and the patients were followed up for 24 months.RESULTS: Treatment success was closely associated with young age, non-farming occupations, shorter history or smoking, normal urine results, initial MDR-TB treatment regimen, increased haemoglobin, direct bilirubin, uric acid and thyroid stimulating hormone (TSH) levels, and lower white blood cell, neutrophil and blood platelet counts (all P < 0.05). On multivariable analysis, increased haemoglobin (hazard ratio [HR] 1.019, 95%CI 1.007-1.032, P = 0.002) and TSH levels (HR 1.002, 95%CI 1.006-1.039, P = 0.008), normal urine results (HR 1.541, 95%CI 1.008-2.358, P = 0.046) and initial MDR-TB treatment regimen (HR 2.238, 95%CI 1.090-4.597, P = 0.028) were prognostic factors for treatment success in MDR-TB.CONCLUSIONS: Higher haemoglobin and TSH levels, normal urine results and initial MDR-TB treatment regimen might predict successful treatment of MDR-TB.
Bibliography:(R) Medicine - General
1027-3719(20180301)22:3L.300;1-
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1027-3719
1815-7920
DOI:10.5588/ijtld.17.0183